Effectiveness of fludarabine, idarubicin and cyclophosphamide (FLUIC) combination regimen for young patients with untreated non-follicular low-grade non-Hodgkin's lymphoma

Leukemia & Lymphoma
P L ZinzaniMichele Baccarani

Abstract

In the last years, fludarabine (FLU) alone or in combination with other drugs has been reported to be effective in the treatment of previously untreated low-grade non-Hodgkin's lymphomas (LG-NHL). We report on the therapeutic efficacy and toxicity of a combination of FLU, idarubicin and cyclophosphamide (FLUIC regimen) in untreated non-follicular LG-NHL. We administered a three-drug combination of FLU (25 mg/m2 i.v. on days 1 to 3), idarubicin (14 mg/m2 i.v. on day 1) and cyclophosphamide (200 mg/m2 i.v. on days 1 to 3) to treat 41 young, previously untreated patients with non-follicular LG-NHL. Chemotherapy was repeated every 4 weeks for a total of 6 cycles. Among 41 patients, 24 (59%) were diagnosed with small lymphocytic, 10 (24%) with immnocytoma, and 7 (17%) with marginal zone subtypes. Nineteen (46%) patients achieved complete response (CR) and 21 (51%) partial response, while the remaining 1 (3%) showed no benefit from the treatment. With respect to histology, we observed CR rates of 38% for the small lymphocytic subtype, 40% for the immunocytoma subtype, and 86% for the marginal zone subtype. Estimated 42-month overall survival and relapse-free survival rates were 64% and 100%, respectively. Hematologic grade 3-4 toxici...Continue Reading

References

May 11, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J R RedmanM J Keating
Jan 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H S HochsterM J O'Connell
Dec 6, 1984·The New England Journal of Medicine·S J Horning, S A Rosenberg
Dec 1, 1982·American Journal of Clinical Oncology·M M OkenP P Carbone
Aug 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R HaasW Hunstein
Mar 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P McLaughlinM Keating
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Aug 1, 1993·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P L ZinzaniR Fanin
Apr 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P McLaughlinF Cabanillas
Apr 1, 1997·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P L ZinzaniS Tura
May 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N R SchechterJ Yahalom
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P McLaughlinB K Dallaire
Mar 17, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M LazzarinoC Bernasconi
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B D ChesonG P Canellos
Nov 30, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T E WitzigA J Grillo-López
Feb 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P L ZinzaniS Tura
Mar 1, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H S HochsterP A Cassileth
May 16, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P L ZinzaniS Tura
Feb 14, 2002·Seminars in Oncology·Myron S CzuczmanSteven H Bernstein
Aug 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas E WitzigChristine A White
Feb 1, 2002·Seminars in Oncology·Myron S CzuczmanSteven H Bernstein

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.